BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$4.89B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$2.11B |
| 3 |
Cigna
CI
|
+$2.09B |
| 4 |
ExxonMobil
XOM
|
+$1.33B |
| 5 |
Verizon
VZ
|
+$1.32B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$4.73B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$3.38B |
| 3 |
PX
Praxair Inc
PX
|
+$2.8B |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$2.28B |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.96% |
| 2 | Healthcare | 14.79% |
| 3 | Financials | 14.43% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Industrials | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
DHT Holdings
DHT
$2.95B
| $18.6M | ﹤0.01% |
4,746,892
+111,286
| +2% | +$516K |
|
2752
Riverview Bancorp
RVSB
$107M
| $18.6M | ﹤0.01% |
2,554,519
+117,129
| +5% | +$940K |
|
2753
Oppenheimer Holdings
OPY
$1.2B
| $18.6M | ﹤0.01% |
726,905
+14,655
| +2% | +$420K |
|
2754
Arcus Biosciences
RCUS
$3.66B
| $18.5M | ﹤0.01% |
1,721,894
+1,286,470
| +295% | +$15M |
|
2755
TG Therapeutics
TGTX
$7.52B
| $18.5M | ﹤0.01% |
4,519,331
+98,479
| +2% | +$489K |
|
|
SRGA
2756
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $18.5M | ﹤0.01% |
166,916
+1,675
| +1% | +$218K |
|
|
FBR
2757
DELISTED
Fibria Celulose Sa
FBR
| $18.5M | ﹤0.01% |
1,075,989
-178,496
| -14% | -$3.29M |
|
|
LTS
2758
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $18.5M | ﹤0.01% |
7,942,707
+53,953
| +0.7% | +$144K |
|
2759
Magnolia Oil & Gas
MGY
$6.16B
| $18.5M | ﹤0.01% |
1,649,863
+1,357,865
| +465% | +$17.1M |
|
2760
Standard BioTools
LAB
$310M
| $18.4M | ﹤0.01% |
2,139,878
+178,429
| +9% | +$1.39M |
|
2761
West Bancorporation
WTBA
$484M
| $18.4M | ﹤0.01% |
964,526
+59,208
| +7% | +$1.25M |
|
2762
Ecopetrol
EC
$35.1B
| $18.4M | ﹤0.01% |
1,158,290
-167,042
| -13% | -$3.58M |
|
2763
Orion Group Holdings
ORN
$396M
| $18.3M | ﹤0.01% |
4,277,159
-19,685
| -0.5% | -$99K |
|
2764
Farmers National Banc Corp
FMNB
$931M
| $18.3M | ﹤0.01% |
1,436,794
+83,906
| +6% | +$1.14M |
|
2765
Northrim BanCorp
NRIM
$588M
| $18.3M | ﹤0.01% |
2,224,692
+114,292
| +5% | +$1.05M |
|
|
AMNB
2766
DELISTED
American National Bankshares Inc
AMNB
| $18.3M | ﹤0.01% |
623,737
+21,194
| +4% | +$745K |
|
2767
CRISPR Therapeutics
CRSP
$5.17B
| $18.3M | ﹤0.01% |
639,235
-70,408
| -10% | -$2.45M |
|
2768
Titan Machinery
TITN
$426M
| $18.2M | ﹤0.01% |
1,383,239
+65,756
| +5% | +$978K |
|
2769
Blue Bird Corp
BLBD
$2.07B
| $18.2M | ﹤0.01% |
999,398
+78,023
| +8% | +$1.52M |
|
|
SRNE
2770
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $18.2M | ﹤0.01% |
7,566,238
+95,416
| +1% | +$312K |
|
|
PHX
2771
DELISTED
PHX Minerals
PHX
| $18.2M | ﹤0.01% |
1,171,021
+5,664
| +0.5% | +$96K |
|
2772
Kiniksa Pharmaceuticals
KNSA
$5.97B
| $18.1M | ﹤0.01% |
645,111
+194,538
| +43% | +$4.06M |
|
2773
Televisa
TV
$1.52B
| $18.1M | ﹤0.01% |
1,440,076
+264,490
| +22% | +$3.87M |
|
2774
Alpha and Omega Semiconductor
AOSL
$1.03B
| $18.1M | ﹤0.01% |
1,772,181
-69,309
| -4% | -$714K |
|
2775
Park-Ohio Holdings
PKOH
$693M
| $18M | ﹤0.01% |
588,085
+35,078
| +6% | +$1.22M |
|
Similar funds
BlackRock's Q4 2018 Portfolio in Review
As of Q4 2018, BlackRock held 5,211 positions worth $1.98T, down 14% from $2.31T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock's Q4 2018 filing shows 169 new, 3,017 increased, 1,308 reduced and 195 closed positions. Its largest new stake was Linde: 30,937,347 shares worth $4.83B. The largest sale was Aetna Inc, an estimated $4.73B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2018 buy was Linde: 30,937,347 shares worth $4.83B.
- BlackRock added most to iShares Core MSCI Total International Stock ETF in Q4 2018, an estimated $2.11B increase.
- BlackRock's biggest Q4 2018 reduction was iShares Russell 1000 ETF, cutting an estimated $2.28B.
- BlackRock fully exited Aetna Inc in Q4 2018, selling an estimated $4.73B.
- BlackRock's ten largest holdings make up 14% of its $1.98T portfolio in Q4 2018.
- BlackRock opened 169 new positions and closed 195 in Q4 2018.
- BlackRock's portfolio value fell 14% quarter-over-quarter to $1.98T.
Based on BlackRock's 13F filing for Q4 2018, filed 8 Feb 2019.